Respiratory infections with pandemic and epidemic potential have been a burden to the human race for as long as history has recorded. Globally, respiratory infections are among the most common cause of morbidity and mortality. While treatments and prevention strategies have been applied, the emergence of antimicrobial resistance threatens the progress that has been made. Additionally, new respiratory infections, particularly linked to interactions between humans and animals, are also emerging.
This year's Congress puts the spotlight on the most up-to-date scientific developments in, and challenges relating to, respiratory infections. There are a number of sessions available, including postgraduate courses, challenging clinical cases, meet the expert sessions, oral presentations, symposia, hot topics, poster discussions and a dedicated assembly group members meeting.
Stefano Aliberti, Head of the ERS Respiratory Infections Assembly, notes: "Antimicrobial resistance and emerging infections threaten the effective management and prevention of a range of respiratory infections, which already represent a significant burden to healthcare services. It is vital that we understand developments in this field if we are to overcome this global public health threat. Sessions at this year's Congress will focus on infection control in epidemics, the treatment of extensively drug-resistant TB and updates in the field of pneumonia and chronic infections, among other topics."
Join the ERS Respiratory Infections Assembly on MyERS.
If you are interested in this topic, here is a list of some associated sessions at this year's Congress. Alternatively, you can browse the full programme and filter your search by 'Infection' for more sessions on this topic.
Note: Educational sessions (postgraduate courses, skills workshops, challenging clinical cases, professional development workshops and meet the expert sessions) can be attended at an additional cost to the standard registration fee.